Sonia Moreno-Grau, Fundació ACE's researcher, has recently published an article that reviews the genetic context of Alzheimer's disease. The article takes into account the generally established three stages of the disease: preclinical, which has no symptoms and in which there are subjective memory complaints, mild cognitive impairment without dementia and moderate-severe stage.
This article presents the genetic perspective of the existing lines and the lines yet to be explored. In addition to collecting existing studies on the subject, Moreno-Grau introduces a meta-analysis, conducted entirely in Fundació ACE, which highlights the need to study healthy populations for new therapeutic targets, ie new ways to treat risk factors for Alzheimer's disease.
Sonia Moreno-Grau is a researcher at Fundació ACE for 2 years. Her specialty is genetics. She studied at the University of Valencia (Pharmacy) and the Autonomous University of Barcelona (UAB) (Master in Biochemistry). She is currently a PhD student of Biochemistry (UAB) and about research in Spain, she believes that lack of resources hinders its development and requires most Spaniard researchers to emigrate, undermining not only the ability to generate knowledge de novo but also the ability to generate a more prosperous society.